Agonists and antagonists of toll-like receptor (TLR) 13

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9556439
APP PUB NO 20140377309A1
SERIAL NO

14377035

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the field of immunology. The present invention provides agonists and antagonists of Toll-like receptor (TLR) 13. In particular, the present invention provides TLR13 activating and inhibiting nucleic acids, and provides such nucleic acids for use as pharmaceutical agents. The present invention further provides in vitro methods using such nucleic acids.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BAVARIAN NORDIC A/SHEJRESKOVVEJ 10A DK3490 KVISTGAARD DENMARK

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bauer, Stefan Marbury-Michelbach, DE 156 2530
Hochrein, Hubertus Munich, DE 20 57
Kirschning, Carsten Essen, DE 2 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 31, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00